Malin Corporation PLC Result of AGM

RNS Number : 8019I

Malin Corporation PLC

28 March 2024

 

 

Malin Corporation plc

 

Results of 2024 Annual General Meeting

 

Dublin-Ireland, 28 March 2024: Malin Corporation plc. (Euronext Growth Dublin:MLC) ("Malin", the "Company"), a company investing in highly innovative life sciences companies, today announces that each of the resolutions proposed at its Annual General Meeting held today in Dublin were passed.

 

The full text of each resolution was included in the Notice of Annual General Meeting of the Company circulated to shareholders on 28 February 2024 and made available on the Company's website.

 

A summary of the voting results for the meeting is available on the Company's website www.malinplc.com.

 

ENDS

 

About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) is a company investing in highly innovative life sciences companies. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses. Malin has a focus on innovative businesses underpinned by exceptional science and works with its investee companies, providing strategic and financial support to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com 

For further information please contact:

 

Malin

Fiona Dunlevy, Company Secretary

Tel: [phone]

[e-mail]

 

Davy Corporate Finance (Euronext Growth Listing Sponsor & Joint Broker)

Brian Garrahy / Daragh O'Reilly

Tel: [phone]

 

Liberum (Joint Broker)

Phil Walker/Ben Cryer

Tel: [phone]

 

Powerscourt (Irish Media enquiries)         

Eavan Gannon

Tel: [phone]                          

[e-mail]  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RAGMZGZFNRLGDZM